Chase Investment Counsel’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-18,077
Closed -$887K – 102
2018
Q4
$887K Sell
18,077
-2,702
-13% -$154K 0.53% 52
2018
Q3
$1.29M Buy
20,779
+481
+2% +$29.2K 0.66% 41
2018
Q2
$1.09M Buy
20,298
+8,099
+66% +$405K 0.59% 45
2018
Q1
$554K Buy
+12,199
New +$523K 0.29% 59

Other funds holding EHC

Chase Investment Counsel's EHC Position: Q1 2019 in Review

Chase Investment Counsel sold out of Encompass Health (EHC) in Q1 2019, closing a stake of 18,077 shares — an estimated $887K sold.

Chase Investment Counsel first reported a position in EHC in Q1 2018 and held it in 4 quarters. The position peaked at $1.29M in Q3 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

  • Chase Investment Counsel reported no remaining Encompass Health position as of Q1 2019 after selling out during the quarter.
  • Chase Investment Counsel sold 18,077 Encompass Health shares in Q1 2019, an estimated $887K.
  • Chase Investment Counsel first reported a position in Encompass Health in Q1 2018 and held it in 4 quarters.
  • Chase Investment Counsel's Encompass Health position peaked at $1.29M in Q3 2018.
  • 427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on Chase Investment Counsel's 13F filing for Q1 2019, filed 3 May 2019.